Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is currently down 0.37% at lunch.
The DuluxGroup Limited (ASX: DLX) share price has jumped 26.7% in response to a takeover approach by Nippon Paint, the DuluxGroup Board have recommended the deal to shareholders.
WATCH NOW: The Australian Investors Podcast Feat.
Global Investing Expert Hamish Douglass
Hamish Douglass is one of Australia's top investors and founders, having co-founded Magellan - a near $9 billion business! Learn exactly how Hamish invests in shares today.
Challenger Ltd (ASX: CGF) shares have declined around 6% in response to the annuity company’s underwhelming third quarter update.
The share price of BHP Group Ltd (ASX: BHP) is down 2% after the resources giant revealed its March 2019 quarter report to investors.
Shares of Australian Pharmaceutical Industries Ltd (ASX: API) are up 0.3% after the pharmacy business announced its half year result.
The Brambles Limited (ASX: BXB) share price is up almost 1% in response to the logistic giant’s March 2019 quarter trading update.
Helloworld Travel Ltd (ASX: HLO) shares are up 10% due to the travel business’ trading update for the nine months to March 2019 which showed a 8% rise in revenue to $260.5 million.
After searching through a market with over 2,000 shares, our lead expert investment analyst has narrowed it down to just 2 of his favourite rapid-growth shares in a FREE report to Rask Media readers.
Over the past five years, these two shares have gone from being 'tiny caps' to being serious contenders for the ASX 200.
Idea #1 is taking on the world, starting with the huge USA market. In a just a few short years the company has snatched market share away from rivals and is on its way to being the market leader.
Idea #2 uses a 'printer and cartridge' type model to get large and established customers: a) using their healthcare industry-leading product, b) paying for it again and again and again... so it's little wonder this company is tipped to grow at a rapid pace in 2019.
Access the free report by clicking here now. Absolutely no credit card or payment details required.
Disclaimer: Any information contained in this article is limited to general financial/investment advice only. The information has not taken into account your specific needs, goals or objectives, so please consider consulting a licenced and trusted adviser before acting on the information. Please read The Rask Group’s Financial Services Guide (FSG) for more information. This article is authorised by Owen Raszkiewicz of The Rask Group, which is a corporate authorised representative No. 1264179 of Strawman Pty Ltd (ACN: 610 908 211) (AFSL: 501 223).
Disclosure: Jaz owns shares of Challenger at the time of writing, but this could change at any time.